Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2015, Article ID 148064, 7 pages
http://dx.doi.org/10.1155/2015/148064
Review Article

Hematopoietic Stem and Immune Cells in Chronic HIV Infection

Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA

Received 6 March 2015; Revised 15 July 2015; Accepted 21 July 2015

Academic Editor: Laura Lasagni

Copyright © 2015 Jielin Zhang and Clyde Crumpacker. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Stuhlmann, D. Jähner, and R. Jaenisch, “Infectivity and methylation of retroviral genomes is correlated with expression in the animal,” Cell, vol. 26, no. 2, pp. 221–232, 1981. View at Publisher · View at Google Scholar · View at Scopus
  2. J. P. Stoye and J. M. Coffin, “A provirus put to work,” Nature, vol. 403, no. 6771, pp. 715–717, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Chávez, S. Kauder, and E. Verdin, “In vivo, in vitro, and in silico analysis of methylation of the HIV-1 provirus,” Methods, vol. 53, no. 1, pp. 47–53, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Yu, W. Lübben, H. Slomka et al., “Nucleic acid-sensing Toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-induced tumors,” Immunity, vol. 37, no. 5, pp. 867–879, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. R. B. Jones, K. E. Garrison, S. Mujib et al., “HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates,” The Journal of Clinical Investigation, vol. 122, no. 12, pp. 4473–4489, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Schlesinger and S. P. Goff, “Silencing of proviruses in embryonic cells: efficiency, stability and chromatin modifications,” EMBO Reports, vol. 14, no. 1, pp. 73–79, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Magiorkinis, D. Blanco-Melo, and R. Belshaw, “The decline of human endogenous retroviruses: extinction and survival,” Retrovirology, vol. 12, no. 1, article 8, 2015. View at Publisher · View at Google Scholar
  8. D. Wolf and S. P. Goff, “Embryonic stem cells use ZFP809 to silence retroviral DNAs,” Nature, vol. 458, no. 7242, pp. 1201–1204, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Wu, X. Mei, D. Zhao et al., “DNA methylation modulates HERV-E expression in CD4+ T cells from systemic lupus erythematosus patients,” Journal of Dermatological Science, vol. 77, no. 2, pp. 110–116, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Zhang and C. Crumpacker, “Eradication of HIV and cure of AIDS, now and how?” Frontiers in Immunology, vol. 4, article 337, 2013. View at Publisher · View at Google Scholar
  11. L. F. Su, B. A. Kidd, A. Han, J. J. Kotzin, and M. M. Davis, “Virus-specific CD4+ memory-phenotype T cells are abundant in unexposed adults,” Immunity, vol. 38, no. 2, pp. 373–383, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Tokoyoda, S. Zehentmeier, A. N. Hegazy et al., “Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow,” Immunity, vol. 30, no. 5, pp. 721–730, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Tokoyoda, S. Zehentmeier, H.-D. Chang, and A. Radbruch, “Organization and maintenance of immunological memory by stroma niches,” European Journal of Immunology, vol. 39, no. 8, pp. 2095–2099, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. Ö. S. Alp, S. Durlanik, D. Schulz et al., “Memory CD8+ T cells colocalize with IL-7+ stromal cells in bone marrow and rest in terms of proliferation and transcription,” European Journal of Immunology, vol. 45, no. 4, pp. 975–987, 2015. View at Publisher · View at Google Scholar
  15. O. Leavy, “T cell memory: a new resting place,” Nature Reviews Immunology, vol. 9, no. 6, p. 392, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Zou, B. Barnett, H. Safah et al., “Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals,” Cancer Research, vol. 64, no. 22, pp. 8451–8455, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Herndler-Brandstetter, K. Landgraf, B. Jenewein et al., “Human bone marrow hosts polyfunctional memory CD4+ and CD8+ T cells with close contact to IL-15-producing cells,” The Journal of Immunology, vol. 186, no. 12, pp. 6965–6971, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. J. P. Monteiro, A. Benjamin, E. S. Costa, M. A. Barcinski, and A. Bonomo, “Normal hematopoiesis is maintained by activated bone marrow CD4+ T cells,” Blood, vol. 105, no. 4, pp. 1484–1491, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Kfoury, F. Mercier, and D. T. Scadden, “SnapShot: the hematopoietic stem cell niche,” Cell, vol. 158, no. 1, p. 228.e1, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. D. T. Scadden, “Nice neighborhood: emerging concepts of the stem cell niche,” Cell, vol. 157, no. 1, pp. 41–50, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. D. D. Ho, A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz, “Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection,” Nature, vol. 373, no. 6510, pp. 123–126, 1995. View at Publisher · View at Google Scholar · View at Scopus
  22. D. D. Ho, “Time to hit HIV, early and hard,” The New England Journal of Medicine, vol. 333, no. 7, pp. 450–451, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Zhang, M. Poznansky, and C. Crumpacker, “Naive and memory CD4+ T cells in HIV eradication and immunization,” The Journal of Infectious Diseases, vol. 206, no. 4, pp. 617–618, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Zhang and C. S. Crumpacker, “Hematopoietic stem and progenitor cells in HIV/AIDS and immune reconstitution,” Cell Research, vol. 20, no. 7, pp. 745–747, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Fried and C. Johnson, “The effect of cyclophosphamide on hematopoietic stem cells,” Radiation Research, vol. 36, no. 3, pp. 521–527, 1968. View at Publisher · View at Google Scholar · View at Scopus
  26. K. A. Dicke and D. W. van Bekkum, “Transplantation of haemopoietic stem cell (HSC) concentrates for treatment of immune deficiency disease,” Advances in Experimental Medicine and Biology, vol. 29, pp. 337–342, 1973. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Hütter, D. Nowak, M. Mossner et al., “Long-term control of HIV by CCR5 delta32/delta32 stem-cell transplantation,” The New England Journal of Medicine, vol. 360, no. 7, pp. 692–698, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Allers, G. Hütter, J. Hofmann et al., “Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation,” Blood, vol. 117, no. 10, pp. 2791–2799, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Holt, J. Wang, K. Kim et al., “Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo,” Nature Biotechnology, vol. 28, no. 8, pp. 839–847, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Esmaeilzadeh, A. Farshbaf, and M. Erfanmanesh, “Autologous hematopoietic stem cells transplantation and genetic modification of CCR5 m303/m303 mutant patient for HIV/AIDS,” Medical Hypotheses, vol. 84, no. 3, pp. 216–218, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Li, L. Krymskaya, J. Wang et al., “Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases,” Molecular Therapy, vol. 21, no. 6, pp. 1259–1269, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. G.-E. E. Ringpis, S. Shimizu, H. Arokium et al., “Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice,” PLoS ONE, vol. 7, no. 12, Article ID e53492, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Jessen, T. M. Allen, and H. Streeck, “How a single patient influenced HIV research—15-year follow-up,” The New England Journal of Medicine, vol. 370, no. 7, pp. 682–683, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Avigdor, P. Goichberg, S. Shivtiel et al., “CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow,” Blood, vol. 103, no. 8, pp. 2981–2989, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. C. J. Eaves, “Hematopoietic stem cells: concepts, definitions, and the new reality,” Blood, vol. 125, no. 17, pp. 2605–2613, 2015. View at Publisher · View at Google Scholar
  36. M. G. Manz and S. Boettcher, “Emergency granulopoiesis,” Nature Reviews Immunology, vol. 14, no. 5, pp. 302–314, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Mohrin, E. Bourke, D. Alexander et al., “Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis,” Cell Stem Cell, vol. 7, no. 2, pp. 174–185, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Milyavsky, O. I. Gan, M. Trottier et al., “A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal,” Cell Stem Cell, vol. 7, no. 2, pp. 186–197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. P. M. Chaudhary and I. B. Roninson, “Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells,” Cell, vol. 66, no. 1, pp. 85–94, 1991. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Uchida, J. Combs, S. Chen, E. Zanjani, R. Hoffman, and A. Tsukamoto, “Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities,” Blood, vol. 88, no. 4, pp. 1297–1305, 1996. View at Google Scholar · View at Scopus
  41. H. Hong, K. Takahashi, T. Ichisaka et al., “Suppression of induced pluripotent stem cell generation by the p53-p21 pathway,” Nature, vol. 460, no. 7259, pp. 1132–1135, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Kawamura, J. Suzuki, Y. V. Wang et al., “Linking the p53 tumour suppressor pathway to somatic cell reprogramming,” Nature, vol. 460, no. 7259, pp. 1140–1144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. R. M. Marión, K. Strati, H. Li et al., “A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity,” Nature, vol. 460, no. 7259, pp. 1149–1153, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Eisele and R. F. Siliciano, “Redefining the viral reservoirs that prevent HIV-1 eradication,” Immunity, vol. 37, no. 3, pp. 377–388, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. G. M. Laird, E. E. Eisele, S. A. Rabi et al., “Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay,” PLoS Pathogens, vol. 9, no. 5, Article ID e1003398, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Shan, H.-C. Yang, S. A. Rabi et al., “Influence of host gene transcription level and orientation on HIV-1 latency in a primary-cell model,” Journal of Virology, vol. 85, no. 11, pp. 5384–5393, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. K. M. Bruner, N. N. Hosmane, and R. F. Siliciano, “Towards an HIV-1 cure: measuring the latent reservoir,” Trends in Microbiology, vol. 23, no. 4, pp. 192–203, 2015. View at Publisher · View at Google Scholar
  48. J. Zhang, D. T. Scadden, and C. S. Crumpacker, “Primitive hematopoietic cells resist HIV-1 infection via p21Waf1/Cip1/Sdi1,” The Journal of Clinical Investigation, vol. 117, no. 2, pp. 473–481, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. E. Clark, F. Santiago, L. Deng et al., “Loss of G1/S checkpoint in human immunodeficiency virus type 1-infected cells is associated with a lack of cyclin-dependent kinase inhibitor p21/Waf1,” Journal of Virology, vol. 74, no. 11, pp. 5040–5052, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Zhang, E. Attar, K. Cohen, C. Crumpacker, and D. T. Scadden, “Silencing p21Waf1/Cip1/Sdi1 expression increases gene transduction efficiency in primitive human hematopoietic cells,” Gene Therapy, vol. 12, no. 19, pp. 1444–1452, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Stier, T. Cheng, R. Forkert et al., “Ex vivo targeting of p21Cip1/Waf1 permits relative expansion of human hematopoietic stem cells,” Blood, vol. 102, no. 4, pp. 1260–1266, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Bergamaschi, A. David, E. Le Rouzic, S. Nisole, F. Barré-Sinoussi, and G. Pancino, “The CDK inhibitor p21Cip1/Waf1 is induced by FcγR activation and restricts the replication of human immunodeficiency virus type 1 and related primate lentiviruses in human macrophages,” Journal of Virology, vol. 83, no. 23, pp. 12253–12265, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Allouch, A. David, S. M. Amie et al., “P21-mediated RNR2 repression restricts HIV-1 replication in macrophages by inhibiting dNTP biosynthesis pathway,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 42, pp. E3997–E4006, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Shen, T. Cheng, F. I. Preffer et al., “Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression,” Journal of Virology, vol. 73, no. 1, pp. 728–737, 1999. View at Google Scholar · View at Scopus
  55. H. Chen, C. Li, J. Huang et al., “CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21,” The Journal of Clinical Investigation, vol. 121, no. 4, pp. 1549–1560, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. X. G. Yu and M. Lichterfeld, “Elite control of HIV: p21 (waf-1/cip-1) at its best,” Cell Cycle, vol. 10, no. 19, pp. 3213–3214, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. E. Pauls, A. Ruiz, E. Riveira-Muñoz et al., “P21 regulates the HIV-1 restriction factor SAMHD1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 14, pp. E1322–E1324, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. L. B. Cohn, I. T. Silva, T. Y. Oliveira et al., “HIV-1 integration landscape during latent and active infection,” Cell, vol. 160, no. 3, pp. 420–432, 2015. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Onafuwa-Nuga, L. A. McNamara, and K. L. Collins, “Towards a cure for HIV: the identification and characterization of HIV reservoirs in optimally treated people,” Cell Research, vol. 20, no. 11, pp. 1185–1187, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. C. M. Durand, G. Ghiaur, J. D. Siliciano et al., “HIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapy,” The Journal of Infectious Diseases, vol. 205, no. 6, pp. 1014–1018, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. L. Josefsson, S. Eriksson, E. Sinclair et al., “Hematopoietic precursor cells isolated from patients on long-term suppressive HIV therapy did not contain HIV-1 DNA,” The Journal of Infectious Diseases, vol. 206, no. 1, pp. 28–34, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. M. E. Ruiz, C. Cicala, J. Arthos et al., “Peripheral blood-derived CD34+ progenitor cells: CXC chemokine receptor 4 and CC chemokine receptor 5 expression and infection by HIV,” The Journal of Immunology, vol. 161, no. 8, pp. 4169–4176, 1998. View at Google Scholar · View at Scopus
  63. S. K. Stanley, S. W. Kessler, J. S. Justement et al., “CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals,” The Journal of Immunology, vol. 149, no. 2, pp. 689–697, 1992. View at Google Scholar · View at Scopus
  64. B. R. Davis, D. H. Schwartz, J. C. Marx et al., “Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo,” Blood, vol. 76, no. 7, pp. 1281–1286, 1990. View at Google Scholar
  65. D. von Laer, F. T. Hufert, T. E. Fenner et al., “CD34+ hematopoietic progenitor cells are not a major reservoir of the human immunodeficiency virus,” Blood, vol. 76, no. 7, pp. 1281–1286, 1990. View at Google Scholar · View at Scopus
  66. D. Hariharan, Y. Li, D. E. Campbell, S. D. Douglas, S. E. Starr, and W. Ho, “Human immunodeficiency virus infection of human placental cord blood CD34+AC133+ stem cells and their progeny,” AIDS Research and Human Retroviruses, vol. 15, no. 17, pp. 1545–1552, 1999. View at Publisher · View at Google Scholar · View at Scopus
  67. E. Urano, Y. Morikawa, and J. Komano, “Novel role of HSP40/DNAJ in the regulation of HIV-1 replication,” Journal of Acquired Immune Deficiency Syndromes, vol. 64, no. 2, pp. 154–162, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. G. Gao, X. Wu, J. Zhou, M. He, J. J. He, and D. Guo, “Inhibition of HIV-1 transcription and replication by a newly identified cyclin T1 splice variant,” The Journal of Biological Chemistry, vol. 288, no. 20, pp. 14297–14309, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Hamasaki, M. Okamoto, and M. Baba, “Identification of novel inhibitors of human immunodeficiency virus type 1 replication by in silico screening targeting cyclin T1/tat interaction,” Antimicrobial Agents and Chemotherapy, vol. 57, no. 3, pp. 1323–1331, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. Z. Euler and G. Alter, “Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication,” AIDS Research and Human Retroviruses, vol. 31, no. 1, pp. 13–24, 2015. View at Publisher · View at Google Scholar
  71. M. Caskey, F. Klein, J. C. Lorenzi et al., “Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117,” Nature, vol. 522, no. 7557, pp. 487–491, 2015. View at Publisher · View at Google Scholar
  72. B. E. Palmer, C. P. Neff, J. LeCureux et al., “In vivo blockade of the PD-1 receptor suppresses HIV-1 viral loads and improves CD4+ T cell levels in humanized mice,” The Journal of Immunology, vol. 190, no. 1, pp. 211–219, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. G. Doitsh, N. L. K. Galloway, X. Geng et al., “Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection,” Nature, vol. 505, no. 7484, pp. 509–514, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. J. A. Church, “Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection,” Pediatrics, vol. 134, supplement 3, pp. 509–514, 2014. View at Google Scholar
  75. T. Pan, S. Wu, X. He et al., “Necroptosis takes place in human immunodeficiency virus type-1 (HIV-1)-infected CD4+ T lymphocytes,” PLoS ONE, vol. 9, no. 4, Article ID e93944, 2014. View at Publisher · View at Google Scholar · View at Scopus
  76. K. M. Detjen, D. Murphy, M. Welzel, K. Farwig, B. Wiedenmann, and S. Rosewicz, “Downregulation of p21Waf/Cip-1 mediates apoptosis of human hepatocellular carcinoma cells in response to interferon-γ,” Experimental Cell Research, vol. 282, no. 2, pp. 78–89, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. S. L. Fink and B. T. Cookson, “Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells,” Infection and Immunity, vol. 73, no. 4, pp. 1907–1916, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. J. A. Park, K.-W. Kim, S. I. Kim, and S. K. Lee, “Caspase 3 specifically cleaves p21Waf1/Cip1 in the earlier stage of apoptosis in SK-HEP-1 human hepatoma cells,” European Journal of Biochemistry, vol. 257, no. 1, pp. 242–248, 1998. View at Publisher · View at Google Scholar · View at Scopus
  79. L. Hu, A. R. Gocke, E. Knapp et al., “Functional blockade of the voltage-gated potassium channel Kv1.3 mediates reversion of T effector to central memory lymphocytes through SMAD3/p21Cip1 signaling,” The Journal of Biological Chemistry, vol. 287, no. 2, pp. 1261–1268, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. L. R. Cockerham and H. Hatano, “Elite control of HIV: is this the right model for a functional cure?” Trends in Microbiology, vol. 23, no. 2, pp. 71–75, 2015. View at Publisher · View at Google Scholar
  81. J. Thornhill, S. Fidler, and J. Frater, “Advancing the HIV cure agenda: the next 5 years,” Current Opinion in Infectious Diseases, vol. 28, no. 1, pp. 1–9, 2015. View at Publisher · View at Google Scholar · View at Scopus